Holden Stuart bought URGN

November 26, 2025 · Form 4 insider transaction

Holden Stuart bought 2,000 shares of UROGEN PHARMA LTD, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 5 days after the transaction.

Direction

Acquired (buy-side)

2,000

Price

N/A

Total value

N/A

InsiderHolden Stuart

Role—

CompanyUROGEN PHARMA LTD (URGN)

Securityordinary shares

Transaction codeM — Option exercise

Transaction dateNovember 26, 2025

Filing dateDecember 1, 2025

Shares owned after2,000

OwnershipDirect

10b5-1 planNo

AmendedNo

Footnotes

Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer

View the original Form 4 on SEC EDGAR